Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

October 01, 2008; Volume 74,Issue 4

Accelerated Communication

  • You have access
    Targeting Ceramide Metabolism with a Potent and Specific Ceramide Kinase Inhibitor
    Christine Graf, Martin Klumpp, Michael Habig, Philipp Rovina, Andreas Billich, Thomas Baumruker, Berndt Oberhauser and Frédéric Bornancin
    Molecular Pharmacology October 2008, 74 (4) 925-932; DOI: https://doi.org/10.1124/mol.108.048652

Articles

  • You have access
    Mitochondrial Complex I Inhibitor Rotenone Inhibits and Redistributes Vesicular Monoamine Transporter 2 via Nitration in Human Dopaminergic SH-SY5Y Cells
    Masahiko Watabe and Toshio Nakaki
    Molecular Pharmacology October 2008, 74 (4) 933-940; DOI: https://doi.org/10.1124/mol.108.048546
  • You have access
    Structural Determinants for Antagonist Pharmacology That Distinguish the ρ1 GABAC Receptor from GABAA Receptors
    Jianliang Zhang, Fenqin Xue and Yongchang Chang
    Molecular Pharmacology October 2008, 74 (4) 941-951; DOI: https://doi.org/10.1124/mol.108.048710
  • You have access
    Keratinocyte-Derived Vascular Endothelial Growth Factor Biosynthesis Represents a Pleiotropic Side Effect of Peroxisome Proliferator-Activated Receptor-γ Agonist Troglitazone but Not Rosiglitazone and Involves Activation of p38 Mitogen-Activated Protein Kinase: Implications for Diabetes-Impaired Skin Repair
    Dana Schiefelbein, Oliver Seitz, Itamar Goren, Jan Philipp Dißmann, Helmut Schmidt, Malte Bachmann, Robert Sader, Gerd Geisslinger, Josef Pfeilschifter and Stefan Frank
    Molecular Pharmacology October 2008, 74 (4) 952-963; DOI: https://doi.org/10.1124/mol.108.049395
  • You have access
    Functional Role of Arginine 375 in Transmembrane Helix 6 of Multidrug Resistance Protein 4 (MRP4/ABCC4)
    Azza A. K. El-Sheikh, Jeroen J. M. W. van den Heuvel, Elmar Krieger, Frans G. M. Russel and Jan B. Koenderink
    Molecular Pharmacology October 2008, 74 (4) 964-971; DOI: https://doi.org/10.1124/mol.107.043661
  • You have access
    Differential Activation and Trafficking of μ-Opioid Receptors in Brain Slices
    Seksiri Arttamangkul, Nidia Quillinan, Malcolm J. Low, Mark von Zastrow, John Pintar and John T. Williams
    Molecular Pharmacology October 2008, 74 (4) 972-979; DOI: https://doi.org/10.1124/mol.108.048512
  • You have access
    Paraxanthine, the Primary Metabolite of Caffeine, Provides Protection against Dopaminergic Cell Death via Stimulation of Ryanodine Receptor Channels
    Serge Guerreiro, Damien Toulorge, Etienne Hirsch, Marc Marien, Pierre Sokoloff and Patrick P. Michel
    Molecular Pharmacology October 2008, 74 (4) 980-989; DOI: https://doi.org/10.1124/mol.108.048207
  • You have access
    Investigation of the Mechanisms Underlying the Differential Effects of the K262R Mutation of P450 2B6 on Catalytic Activity
    Namandjé N. Bumpus and Paul F. Hollenberg
    Molecular Pharmacology October 2008, 74 (4) 990-999; DOI: https://doi.org/10.1124/mol.108.048637
  • You have access
    The α1D-Adrenergic Receptor Induces Vascular Smooth Muscle Apoptosis via a p53-Dependent Mechanism
    Mary L. García-Cazarín, Jennifer L. Smith, Daret K. St. Clair and Michael T. Piascik
    Molecular Pharmacology October 2008, 74 (4) 1000-1007; DOI: https://doi.org/10.1124/mol.108.047993
  • You have access
    Structural Motifs of Importance for the Constitutive Activity of the Orphan 7TM Receptor EBI2: Analysis of Receptor Activation in the Absence of an Agonist
    Tau Benned-Jensen and Mette M. Rosenkilde
    Molecular Pharmacology October 2008, 74 (4) 1008-1021; DOI: https://doi.org/10.1124/mol.108.049676
  • You have access
    Regulation of Neutral Sphingomyelinase-2 (nSMase2) by Tumor Necrosis Factor-α Involves Protein Kinase C-δ in Lung Epithelial Cells
    Christopher J. Clarke, J. Michael Guthrie and Yusuf A. Hannun
    Molecular Pharmacology October 2008, 74 (4) 1022-1032; DOI: https://doi.org/10.1124/mol.108.046250
  • You have access
    Access and Binding of Local Anesthetics in the Closed Sodium Channel
    Iva Bruhova, Denis B. Tikhonov and Boris S. Zhorov
    Molecular Pharmacology October 2008, 74 (4) 1033-1045; DOI: https://doi.org/10.1124/mol.108.049759
  • You have access
    The Induction of Orphan Nuclear Receptor Nur77 Expression by n-Butylenephthalide as Pharmaceuticals on Hepatocellular Carcinoma Cell Therapy
    Yi-Lin Chen, Min-Hui Jian, Chai-Ching Lin, Jung-Cheng Kang, Shee-Ping Chen, Po-Cheng Lin, Putzer-Joseph Hung, Jen-Ren Chen, Wen-Liang Chang, Shinn-Zong Lin and Horng-Jyh Harn
    Molecular Pharmacology October 2008, 74 (4) 1046-1058; DOI: https://doi.org/10.1124/mol.107.044800
  • You have access
    Identification of N-Terminal Receptor Activity-Modifying Protein Residues Important for Calcitonin Gene-Related Peptide, Adrenomedullin, and Amylin Receptor Function
    Tao Qi, George Christopoulos, Richard J. Bailey, Arthur Christopoulos, Patrick M. Sexton and Debbie L. Hay
    Molecular Pharmacology October 2008, 74 (4) 1059-1071; DOI: https://doi.org/10.1124/mol.108.047142
  • You have access
    Patupilone-Induced Apoptosis Is Mediated by Mitochondrial Reactive Oxygen Species through Bim Relocalization to Mitochondria
    N. R. Khawaja, M. Carré, H. Kovacic, M. A. Estève and D. Braguer
    Molecular Pharmacology October 2008, 74 (4) 1072-1083; DOI: https://doi.org/10.1124/mol.108.048405
  • You have access
    Human Proximal Tubular Epithelium Actively Secretes but Does Not Retain Rosuvastatin
    Anja Verhulst, Rachel Sayer, Marc E. De Broe, Patrick C. D'Haese and Colin D. A. Brown
    Molecular Pharmacology October 2008, 74 (4) 1084-1091; DOI: https://doi.org/10.1124/mol.108.047647
  • You have access
    Dysregulation of Purine Nucleotide Biosynthesis Pathways Modulates Cisplatin Cytotoxicity in Saccharomyces cerevisiae
    David Kowalski, Lakshmi Pendyala, Bertrand Daignan-Fornier, Stephen B. Howell and Ruea-Yea Huang
    Molecular Pharmacology October 2008, 74 (4) 1092-1100; DOI: https://doi.org/10.1124/mol.108.048256
  • You have access
    Syntaxin 1A Interaction with the Dopamine Transporter Promotes Amphetamine-Induced Dopamine Efflux
    Francesca Binda, Concetta Dipace, Erica Bowton, Sabrina D. Robertson, Brandon J. Lute, Jacob U. Fog, Minjia Zhang, Namita Sen, Roger J. Colbran, Margaret E. Gnegy, Ulrik Gether, Jonathan A. Javitch, Kevin Erreger and Aurelio Galli
    Molecular Pharmacology October 2008, 74 (4) 1101-1108; DOI: https://doi.org/10.1124/mol.108.048447
  • You have access
    Histamine H2 Receptor Trafficking: Role of Arrestin, Dynamin, and Clathrin in Histamine H2 Receptor Internalization
    Natalia Fernandez, Federico Monczor, Alberto Baldi, Carlos Davio and Carina Shayo
    Molecular Pharmacology October 2008, 74 (4) 1109-1118; DOI: https://doi.org/10.1124/mol.108.045336
  • You have access
    New Insights into the Function of M4 Muscarinic Acetylcholine Receptors Gained Using a Novel Allosteric Modulator and a DREADD (Designer Receptor Exclusively Activated by a Designer Drug)
    Vindhya Nawaratne, Katie Leach, Nur Suratman, Richard E. Loiacono, Christian C. Felder, Blaine N. Armbruster, Bryan L. Roth, Patrick M. Sexton and Arthur Christopoulos
    Molecular Pharmacology October 2008, 74 (4) 1119-1131; DOI: https://doi.org/10.1124/mol.108.049353
  • You have access
    Inhibition of Tumor Growth by Endohedral Metallofullerenol Nanoparticles Optimized as Reactive Oxygen Species Scavenger
    Jun-Jie Yin, Fang Lao, Jie Meng, Peter P. Fu, Yuliang Zhao, Gengmei Xing, Xueyun Gao, Baoyun Sun, Paul C. Wang, Chunying Chen and Xing-Jie Liang
    Molecular Pharmacology October 2008, 74 (4) 1132-1140; DOI: https://doi.org/10.1124/mol.108.048348
  • You have access
    Selective Inhibition of Mitogen-Activated Protein Kinase Phosphatases by Zinc Accounts for Extracellular Signal-Regulated Kinase 1/2-Dependent Oxidative Neuronal Cell Death
    Yeung Ho, Ranmal Samarasinghe, Megan E. Knoch, Marcia Lewis, Elias Aizenman and Donald B. DeFranco
    Molecular Pharmacology October 2008, 74 (4) 1141-1151; DOI: https://doi.org/10.1124/mol.108.049064
  • You have access
    Kinetic Modeling of the Interactions between 4-Methylumbelliferone, 1-Naphthol, and Zidovudine Glucuronidation by UDP-Glucuronosyltransferase 2B7 (UGT2B7) Provides Evidence for Multiple Substrate Binding and Effector Sites
    Verawan Uchaipichat, Aleksandra Galetin, J. Brian Houston, Peter I. Mackenzie, J. Andrew Williams and John O. Miners
    Molecular Pharmacology October 2008, 74 (4) 1152-1162; DOI: https://doi.org/10.1124/mol.108.048645
  • You have access
    Mutations to the Kainate Receptor Subunit GluR6 Binding Pocket That Selectively Affect Domoate Binding
    Yihong Zhang, Naushaba Nayeem and Tim Green
    Molecular Pharmacology October 2008, 74 (4) 1163-1169; DOI: https://doi.org/10.1124/mol.108.048819

Erratum

  • You have access
    Correction to “Identification of a Bis-guanylhydrazone [4,4′-Diacetyldiphenylurea-bis(guanylhydrazone); NSC 109555] as a Novel Chemotype for Inhibition of Chk2 Kinase”
    Molecular Pharmacology October 2008, 74 (4) 1170; DOI: https://doi.org/10.1124/mol.74.4.1170
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 74 (4)
Molecular Pharmacology
Vol. 74, Issue 4
1 Oct 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Accelerated Communication
  • Articles
  • Erratum
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics